Bayesian Capital Management’s Roivant Sciences ROIV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-51,000
| Closed | -$515K | – | 823 |
|
|
2025
Q1 | $515K | Buy |
+51,000
| New | +$515K | 0.09% | 287 |
|
|
2024
Q4 | – | Sell |
-48,800
| Closed | -$563K | – | 947 |
|
|
2024
Q3 | $563K | Buy |
+48,800
| New | +$563K | 0.07% | 350 |
|
|
2023
Q3 | – | Sell |
-26,376
| Closed | -$266K | – | 945 |
|
|
2023
Q2 | $266K | Buy |
+26,376
| New | +$266K | 0.03% | 570 |
|
|
2022
Q4 | – | Sell |
-17,525
| Closed | -$56K | – | 998 |
|
|
2022
Q3 | $56K | Buy |
+17,525
| New | +$56K | 0.01% | 625 |
|